Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ANEST IWATATSE:6381 -1.37%90 ROE % is 13.02% as of Mar. 2026, which is 27% above its 10-year median of 10.26. GuruFocus rates TSE:6381 with a GF Score™ of 90/100 and a GF Value™ of 円1,492.77 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 3,002 Industrial Products companies, ANEST IWATA ranks better than 71.85% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. ANEST IWATA's annualized net income for the quarter that ended in Mar. 2026 was 円6,392 Mil. ANEST IWATA's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was 円49,089 Mil. Therefore, ANEST IWATA's annualized ROE % for the quarter that ended in Mar. 2026 was 13.02%.
The historical rank and industry rank for ANEST IWATA's ROE % or its related term are showing as below:
TSE:6381'
s ROE % Range Over the Past 10 Years
Min: 8.28 Med: 10.26 Max: 13.31
Current: 11.08
During the past 13 years, ANEST IWATA's highest ROE % was 13.31%. The lowest was 8.28%. And the median was 10.26%.
TSE:6381's ROE % is ranked better than 71.85% of 3002
companies
in the Industrial Products industry
Industry Median: 5.85
vs TSE:6381: 11.08
ANEST IWATA (TSE:6381) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
ANEST IWATA ROE % Related Terms
ANEST IWATA ROE % Historical Data
* Premium members only.
The historical data trend for ANEST IWATA's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Industrial Machinery subindustry, ANEST IWATA's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ANEST IWATA ROE % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, ANEST IWATA's ROE % distribution charts can be found below:
* The bar in red indicates where ANEST IWATA's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
ANEST IWATA (TSE:6381) has a ROE % of 13.02% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on ANEST IWATA and its competitors. This is 27% above median its historical median of 10.26. Over the past decade, ANEST IWATA's ROE % has ranged from 8.28 to 13.31. According to the industry distribution chart, ANEST IWATA ranks #845 out of 3002 companies in the Industrial Products industry, placing it in the top 28.1%.
Is ANEST IWATA's ROE % too high?
ANEST IWATA's current ROE % of 13.02% is 27% above median its 10-year median of 10.26. Over the past 10 years, this metric has ranged from a low of 8.28 to a high of 13.31. The Industrial Products industry median ROE % is 5.85. ANEST IWATA's value of 13.02% is 122.6% above this industry median. Based on the distribution chart, ANEST IWATA ranks #845 out of 3002 companies in the Industrial Products industry, which is above the industry midpoint. Overall, ANEST IWATA has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ANEST IWATA's ROE % compare to GEV and ETN?
According to the Industrial Products industry distribution chart, ANEST IWATA ranks #845 out of 3002 companies for ROE %. This puts ANEST IWATA in the upper half of its industry. The industry median ROE % is 5.85. ANEST IWATA's value of 13.02% is 122.6% above this benchmark. Historically, ANEST IWATA's own ROE % has ranged from 8.28 to 13.31 over the past decade. While the company's 10-year median is 10.26 vs. the industry median of 5.85, ANEST IWATA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Industrial Products company?
The median ROE % among Industrial Products companies is 5.85, based on 3,002 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ANEST IWATA's current ROE % of 13.02% is 122.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on ANEST IWATA and its competitors. For the Industrial Products industry, the median ROE % is 5.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ANEST IWATA's current ROE % is 13.02%, which is 27% above median its own 10-year median of 10.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ANEST IWATA stock overvalued right now?
Based on GuruFocus' analysis, ANEST IWATA (TSE:6381) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,492.77, compared to a current price of 円1,729.00 — trading 15.8% above its estimated fair value. The current ROE % is 13.02%, which is 27% above median its 10-year median of 10.26 and 122.6% above the Industrial Products industry median of 5.85. ANEST IWATA's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For ANEST IWATA (TSE:6381), the current ROE % is 13.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ANEST IWATA (TSE:6381) Overvalued in 2026?
Based on GuruFocus' analysis, ANEST IWATA stock appears to be overvalued.
The current stock price of 円1,729.00 is trading 15.8% above its estimated GF Value™ of 円1,492.77.
GuruFocus considers ANEST IWATA to be Modestly Overvalued.
Key valuation signals for TSE:6381:
ROE %: 13.02% (27% above median its 10-year median of 10.26)
GF Value™: 円1,492.77 vs. price of 円1,729.00 (15.8% above fair value)
Industry Position: 122.6% above the Industrial Products median (#845 of 3002)
No single metric tells the full story. See the TSE:6381 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ANEST IWATA Corp manufactures and sells air compressors, pneumatic equipment and pneumatic tools. The company also manufactures and sells vacuum machinery, painting machinery, coating equipment, medical equipment, electric power supply equipment and power transmission equipment.
90GF Score
Get the complete analysis for TSE:6381
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6381 has been successfully added to your 
